Monoclonal Antibodies and Airway Diseases

Monoclonal antibodies, biologics, are a relatively new treatment option for severe chronic airway diseases, asthma, allergic rhinitis, and chronic rhinosinusitis (CRS). In this review, we focus on the physiological and pathomechanisms of monoclonal antibodies, and we present recent study results reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyly, Annina, Laulajainen-Hongisto, Anu, Gevaert, Philippe, Kauppi, Paula, Toppila-Salmi, Sanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763928/
https://www.ncbi.nlm.nih.gov/pubmed/33322143
http://dx.doi.org/10.3390/ijms21249477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763928/
https://www.ncbi.nlm.nih.gov/pubmed/33322143
http://dx.doi.org/10.3390/ijms21249477

Ejemplares similares